Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Auburn National Bancorp Q1 Profit Declines

Auburn National Bancorp. (AUBN: Quote) reported first-quarter net earnings of $1.47 million or $0.40 per share, down from $1.55 million or $0.43 per share last year.

Excluding items, operating net earnings was $1.7 million or $0.46 per share, compared to $1.6 million or $0.44 per share a year ago.

Net interest income for the quarter rose to $5.0 million from $4.8 million a year ago. Net interest margin increased to 3.11 percent from last year's 2.98 percent in the first quarter.

Non-interest income for the quarter rose to $4.9 million from $1.1 million a year ago.

Click here to receive FREE breaking news email alerts for Auburn National Bancorp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
German consumer climate is set to improve slightly in November, ending the downward trend, as income expectations among households strengthened on the back of the strong labor market situation, survey data revealed Friday.The forward-looking consumer confidence index rose slightly to 8.5 in November from 8.4 in October. Software giant Microsoft Corp. said Thursday after the markets closed that its first quarter profit fell 13% from last year, hurt mainly by integration and restructuring costs even as revenue surged 25% thanks to strong sales of its gadgets and cloud-based products. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. After turning lower over the course of the previous session, stocks showed a substantial move back to the upside during trading on Thursday. The gains more than offset yesterday's loss, extending the recovery from the recent sell-off.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.